Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Cancer drug risk equal for black, white women
December 23rd, 2004
Women who take tamoxifen to combat breast cancer have about the same benefits and risks whether they are black or white, according to a U.S. study on the effects of the cancer drug. In the study appearing this week in the Journal of the National Cancer Institute, researchers analyzed data from 13 tamoxifen clinical studies involving more than 20,000 women and compared the outcomes for black and white women. Little difference was found between the races. Among women diagnosed with cancer in one breast, between 2% and 15% will develop cancer in the other, or contralateral, breast. Studies have shown that treatment with tamoxifen will reduce...
Source: Women's Health Weekly (2004-12-23)
|
